These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
||||||||||
(State or other jurisdiction of | (I.R.S. Employer | ||||||||||
incorporation or organization) | Identification No.) | ||||||||||
|
|||||||||||
|
|
|
|||||||||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||||||
|
|
|
||||||
|
|
|
|
☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company |
|
||||||||
Emerging growth company |
|
TABLE OF CONTENTS | PAGE | ||||||||||
Abbreviation/Term | Definition | ||||
2021 10-K | Annual Report on Form 10-K for the year ended December 31, 2021 | ||||
2021 Period | Six months ended June 30, 2021 | ||||
2021 Quarter | Three months ended June 30, 2021 | ||||
2022 Period | Six months ended June 30, 2022 | ||||
2022 Quarter | Three months ended June 30, 2022 | ||||
3ME | Three months ended | ||||
6ME | Six months ended | ||||
AMECO | American Equipment Company, Inc. | ||||
AOCI | Accumulated other comprehensive income (loss) | ||||
APIC | Additional paid-in capital | ||||
ASC | Accounting Standards Codification | ||||
ASU | Accounting Standards Update | ||||
CFIUS | Committee on Foreign Investment in the United States | ||||
Cont Ops | Continuing operations | ||||
COOEC | China's Offshore Oil Engineering Co., Ltd | ||||
COVID | Coronavirus pandemic | ||||
CPS | Convertible preferred stock | ||||
CTA | Currency translation adjustment | ||||
DB plan | Defined benefit pension plan | ||||
Disc Ops | Discontinued operations | ||||
DOE | U.S. Department of Energy | ||||
EPC | Engineering, procurement and construction | ||||
EPS | Earnings (loss) per share | ||||
Exchange Act | Securities Exchange Act of 1934 | ||||
Fluor | Fluor Corporation | ||||
G&A | General and administrative expense | ||||
GAAP | Accounting principles generally accepted in the United States | ||||
ICFR | Internal control over financial reporting | ||||
LNG | Liquefied natural gas | ||||
LOGCAP | Logistics Civil Augmentation Program | ||||
NCI | Noncontrolling interests | ||||
NM | Not meaningful | ||||
NuScale | NuScale Power, LLC | ||||
OCI | Other comprehensive income (loss) | ||||
PP&E | Property, plant and equipment | ||||
RSU | Restricted stock units | ||||
RUPO | Remaining unsatisfied performance obligations | ||||
SEC | Securities and Exchange Commission | ||||
SGI | Stock growth incentive awards | ||||
SMR | Small modular reactor | ||||
Stork | Stork Holding B.V. and subsidiaries | ||||
VIE | Variable interest entity |
3ME
June 30, |
6ME
June 30, |
||||||||||||||||||||||
(in millions, except per share amounts) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Cost of revenue |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Gross profit |
|
|
|
|
|||||||||||||||||||
G&A |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Impairment |
|
(
|
|
(
|
|||||||||||||||||||
Foreign currency gain (loss) |
|
(
|
|
(
|
|||||||||||||||||||
Operating profit (loss) |
|
(
|
|
(
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Interest income |
|
|
|
|
|||||||||||||||||||
Earnings (loss) from Cont Ops before taxes |
|
(
|
|
(
|
|||||||||||||||||||
Income tax (expense) benefit |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Net earnings (loss) from Cont Ops |
|
(
|
|
(
|
|||||||||||||||||||
Less: Net earnings (loss) from Cont Ops
attributable to NCI
|
|
(
|
|
|
|||||||||||||||||||
Net earnings (loss) from Cont Ops attributable to Fluor |
|
(
|
|
(
|
|||||||||||||||||||
Net earnings (loss) from Disc Ops attributable to Fluor |
|
(
|
|
(
|
|||||||||||||||||||
Net earnings (loss) attributable to Fluor | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
Less: Dividends on CPS |
|
|
|
|
|||||||||||||||||||
Net earnings (loss) available to Fluor common stockholders | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
Basic EPS available to Fluor common stockholders | |||||||||||||||||||||||
Net earnings (loss) from Cont Ops | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
Net earnings (loss) from Disc Ops |
|
(
|
|
(
|
|||||||||||||||||||
Diluted EPS available to Fluor common stockholders | |||||||||||||||||||||||
Net earnings (loss) from Cont Ops | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
Net earnings (loss) from Disc Ops |
|
(
|
|
(
|
|||||||||||||||||||
3ME
June 30, |
6ME
June 30, |
|||||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
Net earnings (loss) from Cont Ops | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Net earnings (loss) from Disc Ops |
|
(
|
|
(
|
||||||||||||||||||||||
Net earnings (loss) | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
OCI, net of tax: | ||||||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
(
|
(
|
|
||||||||||||||||||||||
Ownership share of equity method investees’ OCI |
|
|
|
(
|
||||||||||||||||||||||
DB plan adjustments |
|
|
|
|
||||||||||||||||||||||
Unrealized gain (loss) on hedges |
(
|
|
(
|
(
|
||||||||||||||||||||||
Total OCI, net of tax |
(
|
|
|
|
||||||||||||||||||||||
Comprehensive income (loss) |
|
(
|
|
(
|
||||||||||||||||||||||
Less: Comprehensive income (loss) attributable to NCI |
|
(
|
|
|
||||||||||||||||||||||
Comprehensive income (loss) attributable to Fluor | $ |
|
$ |
(
|
$ |
|
$ |
(
|
(in millions, except share and per share amounts) |
June 30,
2022 |
December 31,
2021 |
||||||||||||
ASSETS | ||||||||||||||
Current assets | ||||||||||||||
Cash and cash equivalents ($
|
$ |
|
$ |
|
||||||||||
Marketable securities ($
|
|
|
||||||||||||
Accounts receivable, net ($
|
|
|
||||||||||||
Contract assets ($
|
|
|
||||||||||||
Other current assets ($
|
|
|
||||||||||||
Total current assets |
|
|
||||||||||||
Noncurrent assets | ||||||||||||||
Property, plant and equipment, net ($
|
|
|
||||||||||||
Investments |
|
|
||||||||||||
Deferred taxes |
|
|
||||||||||||
Deferred compensation trusts |
|
|
||||||||||||
Goodwill |
|
|
||||||||||||
Other assets ($
|
|
|
||||||||||||
Total noncurrent assets |
|
|
||||||||||||
Total assets | $ |
|
$ |
|
||||||||||
LIABILITIES AND EQUITY | ||||||||||||||
Current liabilities | ||||||||||||||
Accounts payable ($
|
$ |
|
$ |
|
||||||||||
Short-term debt |
|
|
||||||||||||
Contract liabilities ($
|
|
|
||||||||||||
Accrued salaries, wages and benefits ($
|
|
|
||||||||||||
Other accrued liabilities ($
|
|
|
||||||||||||
Total current liabilities |
|
|
||||||||||||
Long-term debt |
|
|
||||||||||||
Deferred taxes |
|
|
||||||||||||
Other noncurrent liabilities ($
|
|
|
||||||||||||
Contingencies and commitments |
|
|
||||||||||||
Temporary APIC |
|
|
||||||||||||
Equity | ||||||||||||||
Shareholders’ equity | ||||||||||||||
Preferred stock — authorized
|
|
|
||||||||||||
Common stock — authorized
|
|
|
||||||||||||
APIC |
|
|
||||||||||||
AOCI |
(
|
(
|
||||||||||||
Retained earnings |
|
|
||||||||||||
Total shareholders’ equity |
|
|
||||||||||||
NCI |
|
|
||||||||||||
Total equity |
|
|
||||||||||||
Total liabilities and equity | $ |
|
$ |
|
6ME
June 30, |
||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
OPERATING CASH FLOW | ||||||||||||||
Net earnings (loss) | $ |
|
$ |
(
|
||||||||||
Adjustments to reconcile net earnings (loss) to operating cash flow: | ||||||||||||||
Impairment |
(
|
|
||||||||||||
Depreciation and amortization |
|
|
||||||||||||
(Earnings) loss from equity method investments, net of distributions |
(
|
(
|
||||||||||||
(Gain) loss on sales of assets incl. AMECO-North America |
(
|
|
||||||||||||
Stock-based compensation |
|
|
||||||||||||
Deferred taxes |
(
|
|
||||||||||||
Net contributions to employee pension plans |
|
(
|
||||||||||||
Changes in assets and liabilities |
(
|
(
|
||||||||||||
Other |
(
|
(
|
||||||||||||
Operating cash flow |
(
|
(
|
||||||||||||
INVESTING CASH FLOW | ||||||||||||||
Purchases of marketable securities |
(
|
(
|
||||||||||||
Proceeds from the sales and maturities of marketable securities |
|
|
||||||||||||
Capital expenditures |
(
|
(
|
||||||||||||
Proceeds from sales of assets |
|
|
||||||||||||
Proceeds from sale of AMECO-North America |
|
|
||||||||||||
Investments in partnerships and joint ventures |
(
|
(
|
||||||||||||
Other |
|
|
||||||||||||
Investing cash flow |
|
|
||||||||||||
FINANCING CASH FLOW | ||||||||||||||
Proceeds from issuance of CPS |
|
|
||||||||||||
Purchase and retirement of debt |
(
|
(
|
||||||||||||
Dividends paid on CPS |
(
|
|
||||||||||||
Other borrowings (debt repayments) |
|
(
|
||||||||||||
Distributions paid to NCI |
(
|
(
|
||||||||||||
Capital contributions by NCI |
|
|
||||||||||||
Taxes paid on vested restricted stock |
(
|
(
|
||||||||||||
Other |
(
|
|
||||||||||||
Financing cash flow |
(
|
|
||||||||||||
Effect of exchange rate changes on cash |
(
|
|
||||||||||||
Increase (decrease) in cash and cash equivalents |
(
|
|
||||||||||||
Cash and cash equivalents at beginning of period |
|
|
||||||||||||
Cash and cash equivalents at end of period | $ |
|
$ |
|
||||||||||
SUPPLEMENTAL INFORMATION: | ||||||||||||||
Cash paid for interest | $ |
|
$ |
|
||||||||||
Cash paid for income taxes (net of refunds) |
|
|
(in millions, except per share amounts) | Preferred Stock | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
BALANCE AS OF MARCH 31, 2022 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
Net earnings (loss) | — | — | — | — | — | — |
|
|
|
|
||||||||||||||||||||||
OCI | — | — | — | — | — |
(
|
— |
(
|
|
(
|
||||||||||||||||||||||
Dividends on CPS ($
|
— | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||
Distributions to NCI | — | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||
Capital contributions by NCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
Other NCI transactions | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
Stock-based plan activity | — | — | — | — |
|
— |
|
|
— |
|
||||||||||||||||||||||
BALANCE AS OF JUNE 30, 2022 |
|
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
(in millions, except per share amounts) | Preferred Stock | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
BALANCE AS OF DECEMBER 31, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
Net earnings (loss) | — | — | — | — | — | — |
|
|
|
|
||||||||||||||||||||||
OCI | — | — | — | — | — |
|
— |
|
|
|
||||||||||||||||||||||
Dividends on CPS ($
|
— | — | — | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||
Distributions to NCI | — | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||
Capital contributions by NCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
Other NCI transactions | — | — | — | — |
|
— | — |
|
|
|
||||||||||||||||||||||
Stock-based plan activity | — | — |
|
— |
|
— |
|
|
— |
|
||||||||||||||||||||||
BALANCE AS OF JUNE 30, 2022 |
|
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
(in millions, except per share amounts) | Preferred Stock | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
BALANCE AS OF MARCH 31, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
Net earnings (loss) | — | — | — | — | — | — |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
OCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
Issuance of CPS |
|
— | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||
Distributions to NCI | — | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||
Capital contributions by NCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
Other NCI transactions | — | — | — | — |
|
— | — |
|
(
|
|
||||||||||||||||||||||
Stock-based plan activity | — | — | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||
BALANCE AS OF JUNE 30, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
(in millions, except per share amounts) | Preferred Stock | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
BALANCE AS OF DECEMBER 31, 2020 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
Net earnings (loss) | — | — | — | — | — | — |
(
|
(
|
|
(
|
||||||||||||||||||||||
OCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
Issuance of CPS |
|
— | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||
Distributions to NCI | — | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||
Capital contributions by NCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
Other NCI transactions | — | — | — | — |
|
— | — |
|
(
|
(
|
||||||||||||||||||||||
Stock-based plan activity | — | — | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||
BALANCE AS OF JUNE 30, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
3ME
June 30, |
6ME
June 30, |
|||||||||||||||||||||||||
(in millions, except per share amounts) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
Net earnings (loss) from Cont Ops attributable to Fluor | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Less: Dividends on CPS |
|
|
|
|
||||||||||||||||||||||
Net earnings (loss) from Cont Ops available to Fluor common stockholders |
|
(
|
|
(
|
||||||||||||||||||||||
Net earnings (loss) from Disc Ops attributable to Fluor |
|
(
|
|
(
|
||||||||||||||||||||||
Net earnings (loss) available to Fluor common stockholders | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Weighted average common shares outstanding |
|
|
|
|
||||||||||||||||||||||
Diluted effect: | ||||||||||||||||||||||||||
CPS |
|
|
|
|
||||||||||||||||||||||
Stock options, RSUs and performance-based award units |
|
|
|
|
||||||||||||||||||||||
Weighted average diluted shares outstanding |
|
|
|
|
||||||||||||||||||||||
Basic EPS available to Fluor common stockholders: | ||||||||||||||||||||||||||
Net earnings (loss) from Cont Ops | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Net earnings (loss) from Disc Ops |
|
(
|
|
(
|
||||||||||||||||||||||
Diluted EPS available to Fluor common stockholders: | ||||||||||||||||||||||||||
Net earnings (loss) from Cont Ops | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Net earnings (loss) from Disc Ops |
|
(
|
|
(
|
||||||||||||||||||||||
Anti-dilutive securities not included in shares outstanding: | ||||||||||||||||||||||||||
CPS |
|
|
|
|
||||||||||||||||||||||
Stock options, RSU and performance-based award units |
|
|
|
|
3ME
June 30, |
6ME
June 30, |
|||||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
Revenue | ||||||||||||||||||||||||||
Energy Solutions | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Urban Solutions |
|
|
|
|
||||||||||||||||||||||
Mission Solutions |
|
|
|
|
||||||||||||||||||||||
Other |
|
|
|
|
||||||||||||||||||||||
Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Segment profit (loss) | ||||||||||||||||||||||||||
Energy Solutions | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Urban Solutions |
|
(
|
|
(
|
||||||||||||||||||||||
Mission Solutions |
|
|
|
|
||||||||||||||||||||||
Other |
|
|
(
|
(
|
||||||||||||||||||||||
Total segment profit (loss) | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
G&A |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Impairment |
|
(
|
|
(
|
||||||||||||||||||||||
Foreign currency gain (loss) |
|
(
|
|
(
|
||||||||||||||||||||||
Interest income (expense), net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Earnings (loss) from Cont Ops attributable to NCI |
|
(
|
|
|
||||||||||||||||||||||
Earnings (loss) from Cont Ops before taxes | $ |
|
$ |
(
|
$ |
|
$ |
(
|
3ME
June 30, |
6ME
June 30, |
||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
NuScale | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
Stork |
|
|
|
|
|||||||||||||||||||
AMECO |
|
|
|
|
|||||||||||||||||||
Segment profit (loss) | $ |
|
$ |
|
$ |
(
|
$ |
(
|
(in millions) |
June 30,
2022 |
December 31,
2021 |
||||||||||||
Energy Solutions | $ |
|
$ |
|
||||||||||
Urban Solutions |
|
|
||||||||||||
Mission Solutions |
|
|
||||||||||||
Other |
|
|
||||||||||||
Corporate |
|
|
||||||||||||
Total assets | $ |
|
$ |
|
3ME
June 30, |
6ME
June 30, |
|||||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
North America | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Asia Pacific (includes Australia) |
|
|
|
|
||||||||||||||||||||||
Europe |
|
|
|
|
||||||||||||||||||||||
Central and South America |
|
|
|
|
||||||||||||||||||||||
Middle East and Africa |
|
|
|
|
||||||||||||||||||||||
Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
3ME
June 30, |
6ME
June 30, |
||||||||||||||||||||||||||||
(in millions) | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||
Impairment: | |||||||||||||||||||||||||||||
Energy Solutions' equity method investment | $ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Goodwill |
|
|
|
||||||||||||||||||||||||||
Fair value adjustment of Stork and AMECO assets |
|
(
|
|
||||||||||||||||||||||||||
Total impairment | $ |
|
$ |
(
|
$ |
|
3ME
June 30 |
6ME
June 30 |
||||||||||||||||||||||
(In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
U.S statutory federal income tax expense (benefit) | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
Increase (decrease) in taxes resulting from: | |||||||||||||||||||||||
State and local income taxes |
|
|
|
|
|||||||||||||||||||
Valuation allowance, net |
|
|
|
|
|||||||||||||||||||
Foreign tax impact |
(
|
|
(
|
|
|||||||||||||||||||
Noncontrolling interest |
(
|
|
(
|
(
|
|||||||||||||||||||
Other |
|
|
|
|
|||||||||||||||||||
Total income tax expense (benefit) | $ |
|
$ |
|
$ |
|
$ |
|
(in millions) | June 30, 2022 | December 31, 2021 | ||||||
Information about contract assets: | ||||||||
Contract assets | ||||||||
Unbilled receivables - reimbursable contracts | $ |
|
$ |
|
||||
Contract work in progress - lump-sum contracts |
|
|
||||||
Contract assets | $ |
|
$ |
|
||||
Advance billings deducted from contract assets | $ |
|
$ |
|
||||
6ME
June 30, |
||||||||
(in millions) | 2022 | 2021 | ||||||
Information about contract liabilities: | ||||||||
Revenue recognized that was included in contract liabilities as of January 1 | $ |
|
$ |
|
(in millions) | June 30, 2022 | ||||
Within 1 year | $ |
|
|||
1 to 2 years |
|
||||
Thereafter |
|
||||
Total RUPO | $ |
|
(in millions) | June 30, 2022 | December 31, 2021 | |||||||||
Borrowings under credit facility | $ |
|
$ |
|
|||||||
Current: | |||||||||||
2023 Notes | $ |
|
$ |
|
|||||||
Other borrowings |
|
|
|||||||||
Total current | $ |
|
$ |
|
|||||||
Long-term: | |||||||||||
Senior Notes | |||||||||||
2023 Notes | $ |
|
$ |
|
|||||||
2024 Notes |
|
|
|||||||||
Unamortized discount on 2024 Notes |
(
|
(
|
|||||||||
Unamortized deferred financing costs |
(
|
(
|
|||||||||
2028 Notes |
|
|
|||||||||
Unamortized discount on 2028 Notes |
(
|
(
|
|||||||||
Unamortized deferred financing costs |
(
|
(
|
|||||||||
Other long-term borrowings |
|
|
|||||||||
Total long-term | $ |
|
$ |
|
June 30, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Hierarchy | Fair Value Hierarchy | |||||||||||||||||||||||||||||||||||||||||||||||||
(in millions) | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||||||||||||
Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred compensation trusts
(1)
|
$ |
|
$ |
|
$ | — | $ | — | $ |
|
$ |
|
$ | — | $ | — | ||||||||||||||||||||||||||||||||||
Derivative assets
(2)
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign currency |
|
— |
|
— |
|
— |
|
— | ||||||||||||||||||||||||||||||||||||||||||
Commodity |
|
— |
|
— |
|
— |
|
— | ||||||||||||||||||||||||||||||||||||||||||
Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative liabilities
(2)
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign currency | $ |
|
$ | — | $ |
|
$ | — | $ |
|
$ | — | $ |
|
$ | — | ||||||||||||||||||||||||||||||||||
June 30, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||
(in millions) |
Fair Value
Hierarchy |
Carrying
Value |
Fair
Value |
Carrying
Value |
Fair
Value |
||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||
Cash
(1)
|
Level 1 | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
Cash equivalents
(2)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
Marketable securities
(2)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
Notes receivable, including noncurrent portion
(3)
|
Level 3 |
|
|
|
|
||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||
2023 Senior Notes
(4)
|
Level 2 | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
2024 Senior Notes
(4)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
2028 Senior Notes
(4)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
Other borrowings, including noncurrent portion
(5)
|
Level 2 |
|
|
|
|
Performance-based Award Units Granted in 2022 |
Weighted Average
Grant Date Fair Value Per Share |
|||||||
2022 Performance Award Plan |
|
$
|
||||||
2021 Performance Award Plan |
|
$
|
||||||
2020 Performance Award Plan |
|
$
|
Location in Statement of Operations |
3ME
June 30, |
6ME
June 30, |
||||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
Compensation expense related to SGI awards | G&A | $ |
|
$ |
(
|
$ |
|
$ |
|
(in millions) |
June 30,
2022 |
December 31, 2021 | |||||||||
Liabilities associated with SGI awards | $ |
|
$ |
|
3ME
June 30, 2022 |
3ME
June 30, 2021 |
|||||||||||||||||||||||||||||||||||||
(in millions) |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
||||||||||||||||||||||||||||||||
OCI: | ||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustments | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
Ownership share of equity method investees’ OCI |
|
(
|
|
(
|
|
|
||||||||||||||||||||||||||||||||
DB plan adjustments |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Unrealized gain (loss) on hedges |
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
Total OCI |
(
|
(
|
(
|
|
|
|
||||||||||||||||||||||||||||||||
Less: OCI attributable to NCI |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
OCI attributable to Fluor | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
6ME
June 30, 2022 |
6ME
June 30, 2021 |
|||||||||||||||||||||||||||||||||||||
(in millions) |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
||||||||||||||||||||||||||||||||
OCI: | ||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustments | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
Ownership share of equity method investees’ OCI |
|
(
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
DB plan adjustments |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
Unrealized gain (loss) on hedges |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
Total OCI |
|
(
|
|
(
|
|
|
||||||||||||||||||||||||||||||||
Less: OCI attributable to NCI |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
OCI attributable to Fluor | $ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
(in millions) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
Attributable to Fluor: | |||||||||||||||||||||||||||||
Balance as of March 31, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
(
|
|
|
(
|
(
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
Net OCI |
(
|
|
|
(
|
(
|
||||||||||||||||||||||||
Balance as of June 30, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
Attributable to NCI: | |||||||||||||||||||||||||||||
Balance as of March 31, 2022 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
|
|
|
|
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
Net OCI |
|
|
|
|
|
||||||||||||||||||||||||
Balance as of June 30, 2022 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
(in millions) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
Attributable to Fluor: | |||||||||||||||||||||||||||||
Balance as of December 31, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
(
|
|
|
(
|
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
(
|
|
||||||||||||||||||||||||
Net OCI |
(
|
|
|
(
|
|
||||||||||||||||||||||||
Balance as of June 30, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
Attributable to NCI: | |||||||||||||||||||||||||||||
Balance as of December 31, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
|
|
|
|
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
Net OCI |
|
|
|
|
|
||||||||||||||||||||||||
Balance as of June 30, 2022 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
(in millions) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
Attributable to Fluor: | |||||||||||||||||||||||||||||
Balance as of March 31, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
(
|
|
|
|
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
(
|
(
|
||||||||||||||||||||||||
Net OCI |
(
|
|
|
|
|
||||||||||||||||||||||||
Balance as of June 30, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
Attributable to NCI: | |||||||||||||||||||||||||||||
Balance as of March 31, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
(
|
|
|
|
(
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
Net OCI |
(
|
|
|
|
(
|
||||||||||||||||||||||||
Balance as of June 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
(in millions) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
Attributable to Fluor: | |||||||||||||||||||||||||||||
Balance as of December 31, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
|
(
|
|
|
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
(
|
(
|
||||||||||||||||||||||||
Net OCI |
|
(
|
|
(
|
|
||||||||||||||||||||||||
Balance as of June 30, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
Attributable to NCI: | |||||||||||||||||||||||||||||
Balance as of December 31, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
OCI before reclassifications |
(
|
|
|
|
(
|
||||||||||||||||||||||||
Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
Net other comprehensive income (loss) |
(
|
|
|
|
(
|
||||||||||||||||||||||||
Balance as of June 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
3ME
June 30, |
6ME
June 30, |
|||||||||||||||||||||||||||||||
(in millions) | Location in Statement of Operations | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||
Component of AOCI: | ||||||||||||||||||||||||||||||||
Ownership share of equity method investees’ OCI | Cost of revenue | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
Income tax benefit | Income tax expense (benefit) |
|
|
|
|
|||||||||||||||||||||||||||
Net of tax | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
DB plan adjustments | G&A | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||
Income tax benefit | Income tax expense (benefit) |
|
|
|
(
|
|||||||||||||||||||||||||||
Net of tax | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||
Unrealized gain (loss) on derivative contracts: | ||||||||||||||||||||||||||||||||
Commodity and foreign currency contracts |
Various accounts
(1)
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Interest rate contracts | Interest expense |
|
|
|
(
|
|||||||||||||||||||||||||||
Income tax benefit | Income tax expense (benefit) |
|
(
|
|
(
|
|||||||||||||||||||||||||||
Net of tax | $ |
(
|
$ |
|
$ |
|
$ |
|
(in millions) |
3ME
June 30, 2021 |
6ME
June 30, 2021 |
|||||||||||||||||||||
Revenue | $ |
|
$ |
|
|||||||||||||||||||
Cost of revenue |
(
|
(
|
|||||||||||||||||||||
Gross Profit |
(
|
(
|
|||||||||||||||||||||
G&A |
|
|
|||||||||||||||||||||
Impairment expense |
|
|
|||||||||||||||||||||
Loss on sale of AMECO North America |
(
|
(
|
|||||||||||||||||||||
Foreign currency gain (loss) |
|
|
|||||||||||||||||||||
Operating profit |
(
|
(
|
|||||||||||||||||||||
Interest (expense) income, net |
|
|
|||||||||||||||||||||
Earnings (loss) before taxes from Disc Ops |
(
|
(
|
|||||||||||||||||||||
Income tax (expense) benefit |
|
|
|||||||||||||||||||||
Net earnings (loss) from Disc Ops |
(
|
(
|
|||||||||||||||||||||
Less: Net earnings (loss) from Disc Ops attributable to NCI |
|
|
|||||||||||||||||||||
Net earnings (loss) from Disc Ops attributable to Fluor | $ |
(
|
$ |
(
|
(in millions) |
6ME
June 30, 2021 |
||||||||||
Capital expenditures | $ |
(
|
3ME
June 30, |
6ME
June 30, |
||||||||||||||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||||||
Revenue | |||||||||||||||||||||||||||||||||||
Energy Solutions | $ | 1,330 | $ | 1,319 | $ | 2,505 | $ | 2,310 | |||||||||||||||||||||||||||
Urban Solutions | 1,005 | 1,210 | 1,964 | 2,405 | |||||||||||||||||||||||||||||||
Mission Solutions | 547 | 707 | 1,140 | 1,460 | |||||||||||||||||||||||||||||||
Other | 417 | 448 | 813 | 856 | |||||||||||||||||||||||||||||||
Total revenue | $ | 3,299 | $ | 3,684 | $ | 6,422 | $ | 7,031 | |||||||||||||||||||||||||||
Segment profit (loss) $ and margin % | |||||||||||||||||||||||||||||||||||
Energy Solutions | $ | 65 | 4.9% | $ | 109 | 8.3% | $ | 119 | 4.8% | $ | 111 | 4.8% | |||||||||||||||||||||||
Urban Solutions | 8 | 0.8% | (68) | (5.6)% | 23 | 1.2% | (38) | (1.6)% | |||||||||||||||||||||||||||
Mission Solutions | 28 | 5.1% | 45 | 6.4% | 86 | 7.5% | 89 | 6.1% | |||||||||||||||||||||||||||
Other | 7 | NM | 9 | NM | (5) | NM | (6) | NM | |||||||||||||||||||||||||||
Total segment profit (loss) $ and margin %
(1)
|
$ | 108 | 3.3% | $ | 95 | 2.6% | $ | 223 | 3.5% | $ | 156 | 2.2% | |||||||||||||||||||||||
G&A | (45) | (33) | (117) | (100) | |||||||||||||||||||||||||||||||
Impairment | — | (101) | 63 | (148) | |||||||||||||||||||||||||||||||
Foreign currency gain (loss) | 36 | (30) | 18 | (41) | |||||||||||||||||||||||||||||||
Interest expense, net | (1) | (12) | (10) | (30) | |||||||||||||||||||||||||||||||
Earnings (loss) from Cont Ops attributable to NCI | 7 | (7) | 14 | 25 | |||||||||||||||||||||||||||||||
Earnings (loss) from Cont Ops before taxes | 105 | (88) | 191 | (138) | |||||||||||||||||||||||||||||||
Income tax (expense) benefit | (32) | (2) | (63) | (5) | |||||||||||||||||||||||||||||||
Net earnings (loss) from Cont Ops | $ | 73 | $ | (90) | $ | 128 | $ | (143) | |||||||||||||||||||||||||||
Less: Net earnings (loss) from Cont Ops attributable to NCI | 7 | (7) | 14 | 25 | |||||||||||||||||||||||||||||||
Net earnings (loss) from Cont Ops attributable to Fluor | $ | 66 | $ | (83) | $ | 114 | $ | (168) | |||||||||||||||||||||||||||
Less: Dividends on CPS | 10 | 5 | 20 | 5 | |||||||||||||||||||||||||||||||
Net earnings (loss) from Cont Ops available to Fluor common stockholders | $ | 56 | $ | (88) | $ | 94 | $ | (173) | |||||||||||||||||||||||||||
New awards | |||||||||||||||||||||||||||||||||||
Energy Solutions | $ | 1,339 | $ | 661 | $ | 2,021 | $ | 2,270 | |||||||||||||||||||||||||||
Urban Solutions | 1,943 | 617 | 2,541 | 1,679 | |||||||||||||||||||||||||||||||
Mission Solutions | 52 | 92 | 438 | 1,084 | |||||||||||||||||||||||||||||||
Other | 216 | 326 | 476 | 547 | |||||||||||||||||||||||||||||||
Total new awards | $ | 3,550 | $ | 1,696 | $ | 5,476 | $ | 5,580 | |||||||||||||||||||||||||||
New awards related to projects located outside of the U.S. | 54% | 71% | |||||||||||||||||||||||||||||||||
Backlog
(in millions)
|
June 30,
2022 |
December 31,
2021 |
||||||||||||
Energy Solutions | $ | 8,421 | $ | 9,324 | ||||||||||
Urban Solutions | 7,711 | 7,048 | ||||||||||||
Mission Solutions | 1,863 | 2,562 | ||||||||||||
Other | 1,524 | 1,866 | ||||||||||||
Total backlog | $ | 19,519 | $ | 20,800 | ||||||||||
Backlog related to projects located outside of the U.S. | 61% | 65% | ||||||||||||
Backlog related to lump-sum projects | 57% | 59% |
3ME
June 30, |
6ME
June 30, |
||||||||||||||||||||||
(In millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
U.S statutory federal income tax expense (benefit) | $ | 22 | $ | (19) | $ | 40 | $ | (29) | |||||||||||||||
Increase (decrease) in taxes resulting from: | |||||||||||||||||||||||
State and local income taxes | 1 | — | 1 | — | |||||||||||||||||||
Valuation allowance, net | 20 | 10 | 35 | 21 | |||||||||||||||||||
Foreign tax impact | (13) | 9 | (10) | 11 | |||||||||||||||||||
Noncontrolling interest | (2) | 2 | (3) | (4) | |||||||||||||||||||
Other | 4 | — | — | 6 | |||||||||||||||||||
Total income tax expense (benefit) | $ | 32 | $ | 2 | $ | 63 | $ | 5 |
3ME
June 30, |
6ME
June 30, |
|||||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
NuScale
(1)
|
$ | (8) | $ | (18) | $ | (29) | $ | (34) | ||||||||||||||||||
Stork | 12 | 14 | 18 | 17 | ||||||||||||||||||||||
AMECO | 3 | 13 | 6 | 11 | ||||||||||||||||||||||
Segment profit (loss) | $ | 7 | $ | 9 | $ | (5) | $ | (6) | ||||||||||||||||||
(1)
NuScale expenses included in the determination of segment profit were as follows:
|
||||||||||||||||||||||||||
NuScale expenses | $ | (16) | $ | (43) | $ | (62) | $ | (80) | ||||||||||||||||||
Less: DOE Reimbursable expenses | 7 | 16 | 30 | 32 | ||||||||||||||||||||||
NuScale expenses, net | (9) | (27) | (32) | (48) | ||||||||||||||||||||||
Less: Attributable to NCI | 1 | 9 | 3 | 14 | ||||||||||||||||||||||
NuScale profit (loss) | $ | (8) | $ | (18) | $ | (29) | $ | (34) |
3ME
June 30, |
6ME
June 30, |
||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
G&A | |||||||||||||||||||||||
Compensation | $ | 17 | $ | 24 | $ | 71 | $ | 81 | |||||||||||||||
SEC investigation | 6 | 1 | 12 | 4 | |||||||||||||||||||
Reserve for legacy legal claims | 5 | — | 5 | — | |||||||||||||||||||
Facilities | 3 | 4 | 9 | 7 | |||||||||||||||||||
Exit costs | 4 | — | 4 | — | |||||||||||||||||||
Other | 10 | 4 | 16 | 8 | |||||||||||||||||||
G&A | $ | 45 | $ | 33 | $ | 117 | $ | 100 |
6ME
June 30, |
||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
OPERATING CASH FLOW | $ | (133) | $ | (154) | ||||||||||
INVESTING CASH FLOW | ||||||||||||||
Proceeds from sales and maturities (purchases) of marketable securities | 7 | (8) | ||||||||||||
Capital expenditures | (23) | (46) | ||||||||||||
Proceeds from sales of assets | 131 | 43 | ||||||||||||
Proceeds from sale of AMECO-North America | — | 71 | ||||||||||||
Investments in partnerships and joint ventures | (46) | (60) | ||||||||||||
Other | 8 | — | ||||||||||||
Investing cash flow | 77 | — | ||||||||||||
FINANCING CASH FLOW | ||||||||||||||
Proceeds from issuance of CPS | — | 582 | ||||||||||||
Purchase and retirement of debt | (23) | (5) | ||||||||||||
Dividends paid | (20) | — | ||||||||||||
Other borrowings (debt repayments) | 8 | (6) | ||||||||||||
Distributions paid to NCI | (12) | (18) | ||||||||||||
Capital contributions by NCI | — | 106 | ||||||||||||
Other | (7) | (4) | ||||||||||||
Financing cash flow | (54) | 655 | ||||||||||||
Effect of exchange rate changes on cash | (25) | 11 | ||||||||||||
Increase (decrease) in cash and cash equivalents | (135) | 512 | ||||||||||||
Cash and cash equivalents at beginning of period | 2,209 | 2,199 | ||||||||||||
Cash and cash equivalents at end of period | $ | 2,074 | $ | 2,711 | ||||||||||
Cash paid during the period for: | ||||||||||||||
Interest | $ | 28 | $ | 42 | ||||||||||
Income taxes (net of refunds) | 55 | 68 |
3ME
June 30, |
||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Backlog, April 1 | $ | 19,254 | $ | 25,973 | ||||||||||
New awards | 3,550 | 1,696 | ||||||||||||
Adjustments and cancellations, net
(1)
|
(36) | (880) | ||||||||||||
Work performed | (3,249) | (3,636) | ||||||||||||
Backlog, June 30 | $ | 19,519 | $ | 23,153 |
6ME
June 30, |
||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Backlog, January 1 | $ | 20,800 | $ | 25,569 | ||||||||||
New awards | 5,476 | 5,580 | ||||||||||||
Adjustments and cancellations, net
(1)
|
(434) | (1,066) | ||||||||||||
Work performed | (6,323) | (6,930) | ||||||||||||
Backlog, June 30 | $ | 19,519 | $ | 23,153 |
Period |
Total Number
of Shares Purchased |
Average
Price Paid per Share |
Total Number
of Shares Purchased as Part of Publicly Announced Plans or Programs |
Maximum
Number of
Shares that May
Yet Be Purchased
Under the Plans or
Program
(1)
|
||||||||||||||||||||||
April 1 — April 30, 2022 | — | $ | — | — | 10,513,093 | |||||||||||||||||||||
May 1 — May 31, 2022 | — | — | — | 10,513,093 | ||||||||||||||||||||||
June 1 — June 30, 2022 | — | — | — | 10,513,093 | ||||||||||||||||||||||
Total | — | $ | — | — |
Exhibit | Description | |||||||
3.1 | ||||||||
3.2 | ||||||||
3.3 | ||||||||
31.1 | ||||||||
31.2 | ||||||||
32.1 | ||||||||
32.2 | ||||||||
101.INS | Inline XBRL Instance Document.* | |||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |||||||
104 | The cover page from the Company's Q2 2022 10-Q for the three and six months ended June 30, 2022, formatted in Inline XBRL (included in the Exhibit 101 attachments).* |
FLUOR CORPORATION | |||||||||||
Date: | August 5, 2022 | By: | /s/ Joseph L. Brennan | ||||||||
Joseph L. Brennan | |||||||||||
Chief Financial Officer | |||||||||||
Date: | August 5, 2022 | By: | /s/ John C. Regan | ||||||||
John C. Regan | |||||||||||
Chief Accounting Officer |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|